Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Related
Posts
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Part 1: What is hepatitis C and how is it diagnosed?
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Asia Pacific Situational Updates on Generic DAAs – June 2017
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Strategies to Secure Access to Generic HCV Medicines
